Daily Archives: Thursday August 10th, 2017

52 Week High Breakout (10/08/2017)

TITAN 619.15

SIS shares listed with edge


Mumbai: The shares of the country’s leading security company SIS have been listed on the National Stock Exchange and the Bombay Stock Exchange on Thursday. The stock of the company was listed with a slight increase in the value of the IPO.

The initial public issue of the country’s leading security company (IPO) was closed on August 2 and it had set a target to raise Rs 780 crore from the market. The company’s IPO got more than 7 times the subscription. The good thing for the company was that 20 times its application came in its retail category. The share of security service provider SIS India is listed at 879.8 rupees with 8 percent premium.

However, after the listing, the shares of the company were sold and it went up to Rs 841 in the morning trade. But later it was seen again in the recovery. Indeed, the continuous decline in the stock market this week has been influenced by the shares of this company. The company had issued 53.16 lakh shares. Most of the brokerage houses in the market said it was positive to buy this issue.

Starting with Bihar, this company is present in 124 cities with 251 branches and it has 1.5 lakh employees. Along with India, it is present in eight states of Australia and there are 245 customers in it too. It is the second largest in terms of revenue in the securities companies operating in the country.

Sun Pharma’s market capitalization decreased by 1.25 lakh crore in two years 60% loss to investors  


Mumbai: In the last two-three years where the equity market is steadily growing and investors have made good profits, Sun Pharma’s shares have given huge losses to investors during this period. Its shares have come down by 60 per cent since April 2015, while its market capitalization has decreased by 1.25 lakh crore.

According to stock exchange data, Sun Pharma’s stock was at its peak level of Rs 1,151 on April 7, 2015, which is now running around Rs 474. In this period, its market capitalization has come down from Rs 2.38 lakh crore to Rs 1.14 lakh crore from Rs 1.25 lakh crore.

Apart from Sun Pharma, though other healthcare companies, their market capitalization has declined, but Sun Pharma has given more damage to investors. Sun Pharma’s shares went to the lower level of four years on Wednesday. This is because Tara Pharma has more holding in it and this company has seen a 50 per cent decrease in its net profit in the June quarter.

Total sales of the first quarter of TARRO have fallen by 31 percent to $ 161.3 million, which has put pressure on its value in the competitive environment. According to analysts, this kind of pressure is going on in prices in the near future. The company had recently informed stock exchanges that it has acquired 15.9% of the share in a US company.

Talking about the ending period of March 31, 2017, Sun Pharma’s net profit has been Rs 7,846 crore, which is 38.66 percent more than the same period in the previous year. For the last one year, the performance of pharma companies has been under pressure and in the financial year 2019 only this sector can show some good performance.
Google Translate for Business:Translator ToolkitWebsite Translator